Murray, Timothy G.

Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion–Related Events with Brolucizumab

Monés, J., Srivastava, S. K., Jaffe, G. J., Tadayoni, R., Albini, T. A., Kaiser, P. K., Holz, F. G., Korobelnik, J.-F., Kim, I. K., Pruente, C., et al. (2021) · Ophthalmology

Retinal Diseases and TreatmentsOcular Diseases and Behçet’s Syndrome

Cited by 351

Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis

Essman, T. F., Flynn, H. W., Smiddy, W. E., Brod, R. D., Murray, T. G., Davis, J. L., & Rubsamen, P. E. (1997) · Ophthalmic Surgery, Lasers and Imaging Retina

Ocular Infections and TreatmentsAntifungal resistance and susceptibility

Cited by 264

Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab

Witkin, A. J., Hahn, P., Murray, T. G., Arevalo, J. F., Blinder, K. J., Choudhry, N., Emerson, G. G., Goldberg, R. A., Kim, S. J., Pearlman, J., et al. (2020) · Journal of VitreoRetinal Diseases

Retinal Diseases and TreatmentsOcular Diseases and Behçet’s Syndrome

Cited by 183